Dr. Woody, chief executive officer of 180 Life Sciences, discusses in this interview the current research surrounding synthetic cannabinoids as a treatment for chronic pain, as well as the development of a new type of medication that would have the potential to offer the benefits of cannabis without any undesirable effects. Imagine waking up with […]

OQ011, a topical ointment for hand-foot skin reaction-related pain, yielded positive safety and efficacy in part 1 of 2 phase 2 NOVA-II trial. Investigators reported that treatment with OQ011 yielded positive patient-reported outcomes in hand-foot skin reaction (HFSR)–related pain associated with VEGFR inhibitor-based therapies, according to findings from part 1 of the phase 2 NOVA-II […]

Hamid Khoja is the Chief Scientific Officer of FibroBiologics which is developing regenerative medicine using fibroblasts which are one of the most abundant cells in the human body. While stem cell therapy has gotten significant attention, fibroblasts are easier to source and grow. Hamid elaborates, “Just to give you a sense of some of the capabilities […]